Rene Ecochard, M. D. , Ph. D. , Thomas Bouchard, M. D. , Rene Leiva, M

Slides:

Advertisements

Similar presentations

International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology 2003 Karl G. Nygren,

Advertisements

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Study of nucleation status in the second cell cycle of human embryo and its impact on implantation rate Jesus Aguilar, Ph.D., Irene Rubio, Ph.D., Elkin.

Variation in circulating antimüllerian hormone precursor during the periovulatory and acute postovulatory phases of the human ovarian cycle Michael W.

Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women Ana Direito, M.D., Sébastien.

Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

Developmental capacity of in vitro–matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm Luis.

Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation Christophe Roux, M.D.,

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

Infertility evaluation and treatment among women in the United States

Samuel Santos-Ribeiro, M. D. , Johannie Siffain, M. D. , Nikolaos P

Antimüllerian hormone levels and numbers and sizes of antral follicles in regularly menstruating women of reproductive age referenced to true ovulation.

The normal variabilities of the menstrual cycle

Michael M. Alper, M.D. Fertility and Sterility

Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.

Christian Bamberg, M. D. , Christina Fotopoulou, M. D. , Ph. D

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles Angela R. Baerwald, Ph.D.,

Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization.

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Rene Ecochard, M. D. , Ph. D. , Olivia Duterque, M. D. , Rene Leiva, M

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D

Occurrence of postmenopausal-like acidic follicle-stimulating hormone (FSH) isoforms precedes the rise of FSH before menopause Chris M.G. Thomas, Ph.D.,

The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility Alexander M. Quaas, M.D.,

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Prospective evaluation of luteal phase length and natural fertility

Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos

Angela R. Baerwald, Ph. D. , Olufemi A. Olatunbosun, M. D. , Roger A

Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study Donald Tredway, M.D., Ph.D.,

Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.

Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders—an observational pilot study Frederic Mitri,

A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone

Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization Thomas Brodin,

René Ecochard, M. D. Ph. D. , Agnes Guillerm, M. D. , René Leiva, M. D

Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.

Tomer Singer, M. D. , David H. Barad, M. D. , M. S

Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles of ovum donation with normal weight donors José Bellver, M.D., Antonio.

Interaction of apolipoprotein E gene polymorphisms on miscarriage risk in black and white American women Silvia Gamundi-Segura, M.Sc., Elena Torres-Perez,

Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles Karin.

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Cumulative newborn rates increase with the total number of transferred embryos according to an analysis of 15,792 ovum donation cycles Nicolás Garrido,

Relationship between sleep and secretion of gonadotropin and ovarian hormones in women with normal cycles Sandrine Touzet, M.D., Muriel Rabilloud, M.D.,

Kirstine Kirkegaard, M. D. , Johnny Juhl Hindkjaer, M. Sc

“Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss Michelle.

M. Kathleen Clark, Ph. D. , MaryFran R. Sowers, Ph. D

Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.

MaryFran Sowers, Ph. D. , Daniel McConnell, Ph. D

Transient abdominal ovariopexy for adhesion prevention in patients who underwent surgery for severe pelvic endometriosis Jonathan Ouahba, M.D., Patrick.

Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D

Luteal start vaginal micronized progesterone improves pregnancy success in women with recurrent pregnancy loss Mary D. Stephenson, M.D., M.Sc., Dana.

Fertility and Sterility: an evaluation

Paolo Moghetti, M.D. Fertility and Sterility

Cleophas M. Kyama, Ph. D. , Attila Mihalyi, Ph. D

Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.

Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,

Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.

Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles Lauren Johnson, M.D., M.S.C.E., Mary D. Sammel,

Current evaluation of amenorrhea

Genetic evaluation procedures at sperm banks in the United States

A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child Xin Chen, M.D., M.Sc., Shi-ling Chen,

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Comparison of the Ovulation Induction and Hormone Profile Between Anastrozole and Clomiphene Citrate in Women With Infertility H. Wu, P. Chen, N.M. Wang,

A study of luteal phase expression of inhibin, activin, and follistatin subunits in the endometrium of women with recurrent miscarriage Alka Prakash,

Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose–response study Donald Tredway,

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Is chromosome testing of the second miscarriage cost saving

Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment Daniel Bodri, M.D., M.Sc.,

Presentation transcript:

Characterization of hormonal profiles during the luteal phase in regularly menstruating women Rene Ecochard, M.D., Ph.D., Thomas Bouchard, M.D., Rene Leiva, M.D., Saman Abdulla, M.Sc., Olivier Dupuis, M.D., Ph.D., Olivia Duterque, M.D., Marie Garmier Billard, M.D., Hans Boehringer, Ph.D., Christophe Genolini, Ph.D. Fertility and Sterility Volume 108, Issue 1, Pages 175-182.e1 (July 2017) DOI: 10.1016/j.fertnstert.2017.05.012 Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Variations in hormonal profiles according to the length of the luteal phase (continuous black line, <13 days; red dashed line, 13–15 days; green dotted line, 15 or 16 days). Each line represents the geometric average of hormonal levels calculated over, respectively, 70, 132, and 64 cycles. Fertility and Sterility 2017 108, 175-182.e1DOI: (10.1016/j.fertnstert.2017.05.012) Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Relative increase of LH after ovulation according to the number of days from the ovulation day (excluded) to the first day with PDG ≥10 μg/mg Cr. Each point represents the average of LH over all cycles having the same number of days from the ovulation day to the first day with ≥10 μg/mg Cr PDG. Fertility and Sterility 2017 108, 175-182.e1DOI: (10.1016/j.fertnstert.2017.05.012) Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 1 Variations in hormonal profiles according to the maximum follicle size at ovulation (continuous black line: <20 mm, red dashed line: 20–24 mm, green dotted line: >24 mm). Each line represents the geometric average of hormonal levels calculated over respectively 71, 105, and 88 cycles. Fertility and Sterility 2017 108, 175-182.e1DOI: (10.1016/j.fertnstert.2017.05.012) Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions